Name (Synonyms) | Correlation | |
---|---|---|
D016769 | Embolism and Thrombosis NIH | 0.58 |
D054556 | Venous Thromboembolism NIH | 0.38 |
D020246 | Venous Thrombosis NIH | 0.32 |
D011655 | Pulmonary Embolism NIH | 0.32 |
D004617 | Embolism NIH | 0.30 |
D013923 | Thromboembolism NIH | 0.27 |
D013927 | Thrombosis NIH | 0.23 |
D016638 | Critical Illness NIH | 0.14 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002625 | Deep venous thrombosis HPO | 0.32 |
HP:0002204 | Pulmonary embolism HPO | 0.32 |
HP:0001907 | Thromboembolism HPO | 0.24 |
There is one clinical trial.
Severe COVID-19 patients at a high risk of venous thromboembolism. We studied patients in 2 intensive care units of university hospitals in Barcelona and Badalona, Spain. We performed a cut-off screening of deep venous thrombosis (DVT) with bilateral duplex ultrasound to 230 patients.
Description: Patients with symptomatic pulmonary embolism confirmed on the CT-angiography and those with a swollen limb and confirmed deep venous thrombosis on compression ultrasound were considered to have "symptomatic venous thromboembolisms". The remaining patients with positive limb ultrasound or CT-angiography were considered to have "asymptomatic venous thrombembolism"
Measure: Venous thromboembolisms Time: 7 daysDescription: Deaths from all causes during the follow-up
Measure: Deaths Time: 7 days